Key Financial Data Of Reporting Company

STELLA PHARMA CORPORATION - Filing #7248023

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
961,058,000 JPY
269,491,000 JPY
229,067,000 JPY
100,096,000 JPY
205,968,000 JPY
Ordinary profit (loss)
-137,869,000 JPY
-760,208,000 JPY
-775,974,000 JPY
-764,088,000 JPY
-656,392,000 JPY
Profit (loss)
-140,811,000 JPY
-763,749,000 JPY
-778,824,000 JPY
-767,719,000 JPY
-659,244,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
2,859,218,000 JPY
2,938,110,000 JPY
3,300,417,000 JPY
3,808,276,000 JPY
1,999,964,000 JPY
Total number of issued shares
34,034,100 xbrli:shares
31,225,500 xbrli:shares
29,966,300 xbrli:shares
28,676,100 xbrli:shares
20,137,400 xbrli:shares
Net assets
3,207,485,000 JPY
2,377,012,000 JPY
2,752,502,000 JPY
3,079,623,000 JPY
230,718,000 JPY
Total assets
5,417,104,000 JPY
3,820,622,000 JPY
4,329,053,000 JPY
4,718,649,000 JPY
2,048,524,000 JPY
Net assets per share
94.26
75.90
91.51
107.39
11.46
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-4.22
-24.66
-26.97
-27.34
-32.90
Diluted earnings per share
Equity-to-asset ratio
0.5921 xbrli:pure
0.6203 xbrli:pure
0.6335 xbrli:pure
0.6526 xbrli:pure
0.1126 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
140,408,000 JPY
-876,837,000 JPY
-827,669,000 JPY
-1,081,129,000 JPY
-772,811,000 JPY
Net cash provided by (used in) investing activities
287,576,000 JPY
-9,010,000 JPY
-29,925,000 JPY
-350,562,000 JPY
-22,864,000 JPY
Net cash provided by (used in) financing activities
721,253,000 JPY
228,353,000 JPY
291,819,000 JPY
3,829,240,000 JPY
-332,402,000 JPY
Cash and cash equivalents
3,161,471,000 JPY
2,012,233,000 JPY
2,669,727,000 JPY
3,235,502,000 JPY
837,952,000 JPY
Number of employees
43 xbrli:pure
44 xbrli:pure
46 xbrli:pure
43 xbrli:pure
43 xbrli:pure
Average number of temporary employees
3 xbrli:pure
5 xbrli:pure
3 xbrli:pure
4 xbrli:pure
4 xbrli:pure
Total shareholder return
0.635 xbrli:pure
0.483 xbrli:pure
0.642 xbrli:pure
xbrli:pure
xbrli:pure
Total return on share price index
0.824 xbrli:pure
0.945 xbrli:pure
0.948 xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.